The identification of novel variants in genes such as ARID1A, BRIP1, MLH1, PIK3R1, and PTEN expands the understanding of the genetic basis of endometrial cancer, suggesting that a broader spectrum of mutations may contribute to the disease than previously recognized. This evidence concerns the gene ARID1A and endometrial cancer.